NCT00181571View on ClinicalTrials.gov

A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

297

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
ADHD
Interventions
DRUG

methylphenidate HCl (Concerta)

up to a maximum dose of 1.3 mg Concerta/kg/day, and not more than 144 mg/day for any subject regardless of weight.

DRUG

Placebo

up to a maximum dose of 1.3 mg Placebo /kg/day, and not more than 144 mg/day for any subject regardless of weight.

Trial Locations (1)

02138

Massachusetts General Hospital, Cambridge

All Listed Sponsors
collaborator

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT00181571 - A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder | Biotech Hunter | Biotech Hunter